http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-083267-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4188 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4188 |
filingDate | 2011-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2013-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AR-083267-A1 |
titleOfInvention | PHARMACEUTICAL COMBINATIONS |
abstract | Pharmaceutical combination comprising: (a) a catalytic mTor inhibitor, such as a catalytic phosphatidyl-inositol-3 kinase (PI3K), and an mTor inhibitor compound, which is an imidazo-quinoline derivative, and (b) at least one mTor inhibitor alloesteric compound, and optionally, at least one pharmaceutically acceptable carrier, for simultaneous, separate, or sequential use, in particular for the treatment of kinase-dependent proliferative diseases of the mammalian target of rapamycin (mTOR ); and to the uses of this combination in the treatment of mTor kinase-dependent proliferative diseases; to a pharmaceutical composition, which comprises said combination; to the use of this combination for the preparation of a medicament for the treatment of a proliferative disease; to a commercial package or product comprising this combination as a combined preparation, for simultaneous, separate, or sequential use; and to a method for treating a warm-blooded animal, especially a human being. |
priorityDate | 2010-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422062140 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12954996 |
Total number of triples: 21.